Waldmann TA - Search Results

1

The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.

Waldmann TA, White JD, Goldman CK, Top L, Grant A, Bamford R, Roessler E, Horak ID, Zaknoen S, Kasten-Sportes C, et al. Waldmann TA, et al. Blood. 1993 Sep 15;82(6):1701-12. Blood. 1993. PMID: 8400227 Free article.

2

Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells.

Broder S, Poplack D, Whang-Peng J, Durm M, Goldman C, Muul L, Waldmann TA. Broder S, et al. Among authors: waldmann ta. N Engl J Med. 1978 Jan 12;298(2):66-72. doi: 10.1056/NEJM197801122980202. N Engl J Med. 1978. PMID: 304175

3

Prolongation of graft survival in primate allograft transplantation by yttrium-90-labeled anti-Tac in conjunction with granulocyte colony-stimulating factor.

Parenteau GL, Dirbas FM, Garmestani K, Brechbiel MW, Bukowski MA, Goldman CK, Clark R, Gansow OA, Waldmann TA. Parenteau GL, et al. Among authors: waldmann ta. Transplantation. 1992 Dec;54(6):963-8. doi: 10.1097/00007890-199212000-00004. Transplantation. 1992. PMID: 1281566

4

The interleukin-2 receptor: a target for immunotherapy.

Waldmann TA, Goldman C, Top L, Grant A, Burton J, Bamford R, Roessler E, Horak I, Zaknoen S, Kasten-Sportes C, et al. Waldmann TA, et al. Adv Exp Med Biol. 1992;323:57-66. doi: 10.1007/978-1-4615-3396-2_8. Adv Exp Med Biol. 1992. PMID: 1485565 Review. No abstract available.

5

The interleukin 2 receptor (IL-2R): the IL-2R alpha subunit alters the function of the IL-2R beta subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R alpha subunit.

Grant AJ, Roessler E, Ju G, Tsudo M, Sugamura K, Waldmann TA. Grant AJ, et al. Among authors: waldmann ta. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2165-9. doi: 10.1073/pnas.89.6.2165. Proc Natl Acad Sci U S A. 1992. PMID: 1549576 Free PMC article.

6

Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection.

Waldmann TA. Waldmann TA. Annu Rev Immunol. 1992;10:675-704. doi: 10.1146/annurev.iy.10.040192.003331. Annu Rev Immunol. 1992. PMID: 1590999 Review.

7

Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia.

Debatin KM, Goldmann CK, Bamford R, Waldmann TA, Krammer PH. Debatin KM, et al. Among authors: waldmann ta. Lancet. 1990 Mar 3;335(8688):497-500. doi: 10.1016/0140-6736(90)90735-n. Lancet. 1990. PMID: 1689786

8

The multichain interleukin-2 receptor: a target for immunotherapy.

Waldmann TA, Pastan IH, Gansow OA, Junghans RP. Waldmann TA, et al. Ann Intern Med. 1992 Jan 15;116(2):148-60. doi: 10.7326/0003-4819-116-2-148. Ann Intern Med. 1992. PMID: 1727619 Review.

9

Lymphokine receptor-directed therapy: a model for immune intervention in leukemia, autoimmunity, and immunodeficiency.

Waldmann TA. Waldmann TA. Clin Immunol Immunopathol. 1991 Nov;61(2 Pt 2):S37-46. doi: 10.1016/s0090-1229(05)80036-4. Clin Immunol Immunopathol. 1991. PMID: 1934612 Review.

10

Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor.

Burton J, Goldman CK, Rao P, Moos M, Waldmann TA. Burton J, et al. Among authors: waldmann ta. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7329-33. doi: 10.1073/pnas.87.18.7329. Proc Natl Acad Sci U S A. 1990. PMID: 1976256 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

654 results

Search Page

Filters